France


Indication:
Olanzapine is indicated for the treatment of a moderate to severe manic episode. In bipolar patients with a manic episode that has responded to olanzapine treatment, olanzapine is indicated for the prevention of recurrence.
Brand name: Zyprexa.
Regulatory status: In France, olanzapine is not registered for bipolar disorder.
Launch date: Not available.